{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T18:43:01Z","timestamp":1786128181624,"version":"build-2736575974"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hebei Province Medical Science Research Project Plan","award":["20260942, 20230225"],"award-info":[{"award-number":["20260942, 20230225"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Liver cancer is a major public health issue in five East Asian countries, with metabolic factors becoming primary drivers. Based on the Global Burden of Disease (GBD) 2023 database, we extracted the total number and age-standardized mortality rates, years lived with disability (YLDs), years of life lost (YLLs) and disability-adjusted life years (DALYs) related to liver cancer attributable to metabolic risks (LC-MR). We analyzed the disease burden of LC-MR and trends across five East Asian countries from 1990 to 2023, examining patterns by sex and age as well as key drivers across different nations, and projected future trends through 2053. In 2023, Mongolia exhibited the highest age-standardized rates for LC-MR, while China ranked first in the total absolute number of cases. From 1990 to 2023, the overall disease burden showed a downward trend in Japan and Republic of Korea, whereas an upward trend was observed in Mongolia, Democratic People\u2019s Republic of Korea, and China. Significant sex and age disparities were observed across all countries in that males bore a higher burden and the burden generally shifted towards the elderly population. Decomposition analysis revealed that the changes in disease burden in Japan and Republic of Korea were primarily driven by population ageing, whereas the main drivering factors were epidemiological changes and population growth in Mongolia and Democratic People\u2019s Republic of Korea. Projections of disease burden for 2053 indicate that the disparities among countries would further widen. Therefore, strengthening metabolic risk interventions and implementing targeted prevention strategies for high-risk populations, especially the aging population, is crucial for reducing the regional burden of LC-MR, given the risk disparities across different countries.<\/jats:p>","DOI":"10.1371\/journal.pone.0342628","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:46:26Z","timestamp":1786124786000},"page":"e0342628","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disease burden and prediction of liver cancer attributable to metabolic risks in five East Asian countries from 1990 to 2023"],"prefix":"10.1371","volume":"21","author":[{"given":"Jialu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8145-8568","authenticated-orcid":true,"given":"Huimin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"issue":"3","key":"pone.0342628.ref001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin","volume":"74","author":"F Bray","year":"2024"},{"issue":"10504","key":"pone.0342628.ref002","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(25)01042-6","article-title":"The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment","volume":"406","author":"SL Chan","year":"2025","journal-title":"Lancet"},{"issue":"7","key":"pone.0342628.ref003","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/ueg2.70072","article-title":"The Rising Global Burden of MASLD and Other Metabolic Diseases (2000-2021","volume":"13","author":"P Danpanichkul","year":"2025","journal-title":"). United Eur Gastroenterol J"},{"issue":"5","key":"pone.0342628.ref004","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/hep.29660","article-title":"Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies","volume":"67","author":"TG Simon","year":"2018","journal-title":"Hepatology"},{"key":"pone.0342628.ref005","doi-asserted-by":"crossref","first-page":"1454161","DOI":"10.3389\/fonc.2024.1454161","article-title":"The role of metabolic reprogramming in liver cancer and its clinical perspectives","volume":"14","author":"M Lu","year":"2024","journal-title":"Front Oncol"},{"key":"pone.0342628.ref006","doi-asserted-by":"crossref","first-page":"101420","DOI":"10.1016\/j.mam.2025.101420","article-title":"Cross-talk between cancer and diabetes: Exploring shared molecular pathways in cellular metabolism and signaling","volume":"106","author":"Z Tang","year":"2025","journal-title":"Mol Aspects Med"},{"issue":"09","key":"pone.0342628.ref007","first-page":"1721","article-title":"The prevalence of metabolic related fatty liver disease in Asia","volume":"41","author":"W Huang","year":"2025","journal-title":"J Clin Hepatol"},{"issue":"06","key":"pone.0342628.ref008","first-page":"1043","article-title":"Abstract and interpretation of the 2025 APASL Clinical Practice Guidelines: Diagnosis and management of metabolic associated fatty liver disease","volume":"41","author":"S Lei","year":"2025","journal-title":"J Clin Hepatol"},{"issue":"6","key":"pone.0342628.ref009","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3904\/kjim.2024.351","article-title":"Understanding the epidemiology of metabolic dysfunction-associated steatotic liver disease is essential for its management: need for attention to accurate diagnostic coding and classification","volume":"39","author":"HA Lee","year":"2024","journal-title":"Korean J Intern Med"},{"issue":"3","key":"pone.0342628.ref010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00535-019-01645-y","article-title":"Transition in the etiology of liver cirrhosis in Japan: a nationwide survey","volume":"55","author":"H Enomoto","year":"2020","journal-title":"J Gastroenterol"},{"issue":"2","key":"pone.0342628.ref011","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12072-024-10763-6","article-title":"Burden, trends, and predictions of liver cancer in China, Japan, and South Korea: analysis based on the Global Burden of Disease Study 2021","volume":"19","author":"S Yang","year":"2025","journal-title":"Hepatol Int"},{"issue":"10513","key":"pone.0342628.ref012","first-page":"1873","article-title":"1990-2023: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","author":"Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations","journal-title":"Lancet"},{"issue":"2","key":"pone.0342628.ref013","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"GBD 2019 Dementia Forecasting Collaborators","year":"2022","journal-title":"Lancet Public Health"},{"issue":"1","key":"pone.0342628.ref014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40364-024-00718-2","article-title":"Global, regional, and national burden of esophageal cancer: a systematic analysis of the Global Burden of Disease Study 2021","volume":"13","author":"W Jin","year":"2025","journal-title":"Biomark Res"},{"key":"pone.0342628.ref015","article-title":"The global, regional, and national patterns of change in the burden of congenital birth defects, 1990-2021: an analysis of the global burden of disease study 2021 and forecast to 2040","volume":"77","author":"Z Bai","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"5","key":"pone.0342628.ref016","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.hbpd.2025.04.007","article-title":"The outcomes and mechanisms of chronic hepatitis B complicated by metabolic dysfunction-associated steatotic liver disease","volume":"24","author":"M-P Li","year":"2025","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"10","key":"pone.0342628.ref017","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.3390\/jcm14103422","article-title":"Escmid Study Group For Viral Hepatitis E. When Metabolic Dysfunction-Associated Steatotic Liver Disease Meets Viral Hepatitis","volume":"14","author":"I Hasanoglu","year":"2025","journal-title":"J Clin Med"},{"issue":"4","key":"pone.0342628.ref018","article-title":"Metabolic dysfunction and alcohol-associated liver disease (MetALD). eGastroenterology","volume":"3","author":"B Gao","year":"2025"},{"issue":"9","key":"pone.0342628.ref019","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/jgh.14989","article-title":"Long-term outcomes of non-alcoholic fatty liver disease and the risk factors for mortality and hepatocellular carcinoma in a Japanese population","volume":"35","author":"T Kogiso","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"pone.0342628.ref020","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.21873\/anticanres.14999","article-title":"Obesity and Liver Cancer in Japan: A Comprehensive Review","volume":"41","author":"H Nishikawa","year":"2021","journal-title":"Anticancer Res"},{"issue":"6","key":"pone.0342628.ref021","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3904\/kjim.2024.164","article-title":"Evolving epidemiology of non-alcoholic fatty liver disease in South Korea: incidence, prevalence, progression, and healthcare implications from 2010 to 2022","volume":"39","author":"JW Park","year":"2024","journal-title":"Korean J Intern Med"},{"issue":"5","key":"pone.0342628.ref022","first-page":"741","article-title":"Metabolic factors and subsequent risk of hepatocellular carcinoma by hepatitis virus infection status: a large-scale population-based cohort study of Japanese men and women (JPHC Study Cohort II)","volume":"20","author":"M Inoue","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"1","key":"pone.0342628.ref023","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/s41598-022-05444-z","article-title":"Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019","volume":"12","author":"M Nakano","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0342628.ref024","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3350\/cmh.2021.0395","article-title":"Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly","volume":"29","author":"YE Chon","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"3","key":"pone.0342628.ref025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3350\/cmh.2024.0145","article-title":"Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study","volume":"30","author":"S Jeong","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"pone.0342628.ref026","doi-asserted-by":"crossref","first-page":"1381173","DOI":"10.3389\/fonc.2024.1381173","article-title":"The burden of liver cancer in Mongolia from 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"14","author":"O Batsaikhan","year":"2024","journal-title":"Front Oncol"},{"issue":"3","key":"pone.0342628.ref027","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s10528-023-10527-1","article-title":"Mongolian HCC vs. Caucasian HCC: The Metabolic Reprogramming Process in Mongolian HCC is an Interesting Difference","volume":"62","author":"R Huang","year":"2024","journal-title":"Biochem Genet"},{"issue":"2","key":"pone.0342628.ref028","article-title":"Prognostic and predictive effects of new steatotic liver disease nomenclatures: a large population-based study","volume":"6","author":"H Zeng","year":"2025","journal-title":"MedComm (2020)"},{"issue":"11","key":"pone.0342628.ref029","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3345\/cep.2021.00192","article-title":"Changes in health status of North Korean children and emerging health challenges of North Korean refugee children","volume":"64","author":"S-W Choi","year":"2021","journal-title":"Clin Exp Pediatr"},{"issue":"11","key":"pone.0342628.ref030","article-title":"Double burden of malnutrition and obesity in children and adolescents from North Korean refugee families","volume":"15","author":"S-Y Kim","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"pone.0342628.ref031","doi-asserted-by":"crossref","first-page":"23255","DOI":"10.1038\/s41598-025-06617-2","article-title":"Trends and future projections of liver cancer attributable to metabolic dysfunction-associated steatohepatitis in China from 1990 to 2050","volume":"15","author":"J Tang","year":"2025","journal-title":"Sci Rep"},{"issue":"2","key":"pone.0342628.ref032","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/ajcn\/nqab099","article-title":"Metabolic risk factors, genetic predisposition, and risk of severe liver disease in Chinese: a prospective study of 0.5 million people","volume":"114","author":"Y Pang","year":"2021","journal-title":"Am J Clin Nutr"},{"issue":"14","key":"pone.0342628.ref033","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1097\/CM9.0000000000003726","article-title":"Global and Chinese burden of non-alcoholic fatty liver disease in chronic liver disease: Findings from the Global Burden of Disease Study 2021","volume":"138","author":"X Zhao","year":"2025","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"pone.0342628.ref034","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological Features of NAFLD From 1999 to 2018 in China","volume":"71","author":"J Zhou","year":"2020","journal-title":"Hepatology"},{"issue":"30","key":"pone.0342628.ref035","article-title":"Elevated fasting serum glucose levels increase the risk of hepatocellular carcinoma: A prospective cohort study","volume":"98","author":"T Liu","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"pone.0342628.ref036","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3350\/cmh.2022.0316","article-title":"Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990-2019: A DALY-based analysis of the Global Burden of Disease 2019 study","volume":"29","author":"S Choi","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"pone.0342628.ref037","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","article-title":"Global, regional and national burden of primary liver cancer by subtype","volume":"161","author":"H Rumgay","year":"2022","journal-title":"Eur J Cancer"},{"issue":"47","key":"pone.0342628.ref038","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035740","article-title":"Risk factors and prevention of liver cancer: A bibliometric and visual analysis","volume":"102","author":"M Yang","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"5834","key":"pone.0342628.ref039","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.1140485","article-title":"Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production","volume":"317","author":"WE Naugler","year":"2007","journal-title":"Science"},{"key":"pone.0342628.ref040","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/apt.18286","article-title":"Metabolic dysfunction-associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: A nationwide cohort study","volume":"60","author":"Y Park","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"pone.0342628.ref041","doi-asserted-by":"crossref","first-page":"224","DOI":"10.14740\/gr2053","article-title":"Predictors of development of hepatocellular carcinoma in non-cirrhotic patients with metabolic dysfunction-associated steatotic liver disease\/metabolic dysfunction-associated steatohepatitis - a retrospective analysis of the national inpatient sample database","volume":"18","author":"S Dhruv","year":"2025","journal-title":"Gastroenterology Res"},{"issue":"12","key":"pone.0342628.ref042","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-7568(22)00272-0","article-title":"Ageing populations: unaffordable demography","volume":"3","author":"The Lancet Healthy Longevity","year":"2022","journal-title":"Lancet Healthy Longev"},{"key":"pone.0342628.ref043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.20892\/j.issn.2095-3941.2024.0149","article-title":"Attributable liver cancer deaths and disability-adjusted life years in China and worldwide: profiles and changing trends","author":"M Cao","year":"2024","journal-title":"Cancer Biol Med"},{"key":"pone.0342628.ref044","doi-asserted-by":"crossref","first-page":"04167","DOI":"10.7189\/jogh.13.04167","article-title":"Global epidemiology of early-onset liver cancer attributable to specific aetiologies and risk factors from 2010 to 2019","volume":"13","author":"C Guo","year":"2023","journal-title":"J Glob Health"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0342628","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:46:33Z","timestamp":1786124793000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0342628"}},"subtitle":[],"editor":[{"given":"Miquel","family":"Vall-llosera Camps","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0342628","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]}}}